record_id
stringlengths
24
36
publication_number
stringlengths
10
16
language
stringclasses
5 values
section
stringclasses
2 values
text
stringlengths
703
858k
ground_truth
listlengths
0
4.56k
chemner-CN108452553B-description
CN108452553B
CN
description
技术领域<b class="d_n">[0001]</b>本发明涉及气凝胶生产应用领域,特别是一种气凝胶用醇水回收装置。背景技术<b class="d_n">[0002]</b>气凝胶是在保持凝胶骨架结构完整的情况下,将凝胶内溶剂干燥后的产物,其是一种具有纳米多孔结构的非晶态低密度材料。二氧化硅气凝胶又被称作“蓝烟”、“固体烟”,是目前已知的最轻的固体材料,也是迄今为止保温性能最好的材料,被誉为“改变世界的神奇材料”。<b class="d_n">[0003]</b>现下,硅气凝胶的制备多是使用单一法制备,在进行超临界干燥前,需使用无水乙醇对凝胶中的溶剂进行置换,将其中的水置换出来,以降低在超临界干燥产生的毛线管力;一般置换后,都会...
[ { "start": 144, "end": 148, "text": "二氧化硅", "label": "ChemicalCompound", "smiles": "O=[Si]=O", "inchikey": "VYPSYNLAJGMNEJ-UHFFFAOYSA-N", "mention_form": "SYSTEMATIC_NAME" } ]
chemner-CN108452553B-claim
CN108452553B
CN
claim
<div class="indep-clm" num="1"><seg-con>1.一种气凝胶用醇水回收装置,包括补热器、乙醇脱水塔、分子筛、冷凝器、缓存罐、分离罐、水中转箱和无水乙醇中转箱,</seg-con><seg-trans>其特征在于,</seg-trans><seg-refi>所述补热器与乙醇脱水塔的气相进口相连,所述乙醇脱水塔的气相出口与分子筛相连,所述分子筛包括第一出口和第二出口,所述第一出口连接冷凝器,所述第二出口连接补热器;</seg-refi></div><div class="indep-clm" num="1"><seg-refi>所述冷凝器一侧连接真空泵,其出口连接缓存罐;所述分离罐内设有隔板和内筒,所述...
[]
chemner-CN117229131A-description
CN117229131A
CN
description
技术领域<b class="d_n">[0001]</b>本发明涉及农药领域,具体涉及一种1-苯基-3-(3-三氟甲基苯基)-2-丙酮的制备方法。背景技术<b class="d_n">[0002]</b>1-苯基-3-(3-三氟甲基苯基)-2-丙酮是合成氟啶草酮的一个重要中间体,氟啶草酮也称为氟啶酮(Fluridone),属于吡咯烷酮类除草剂,可用于防除大多数水中或水面杂草,也可作为芽前选择性除草剂,用于防除棉花一年生窄叶、阔叶杂草及某些多年杂草,还适用于某些对草甘膦产生抗性的杂草,如长芒苋等。<b class="d_n">[0003]</b>目前,1-苯基-3-(3-三氟甲基苯基)-2-丙酮的制备通常通过间三氟甲基苯乙腈和苯乙酸乙...
[ { "start": 3353, "end": 3355, "text": "硫酸", "label": "ChemicalCompound", "smiles": "OS(O)(=O)=O", "inchikey": "QAOWNCQODCNURD-UHFFFAOYSA-N", "mention_form": "SYSTEMATIC_NAME" }, { "start": 3359, "end": 3361, "text": "醋酸", "label": "ChemicalCompound", "smiles": "CC...
chemner-CN117229131A-claim
CN117229131A
CN
claim
<div class="indep-clm" num="1"><seg-con>1.一种1-苯基-3-(3-三氟甲基苯基)-2-丙酮的制备方法,</seg-con><seg-trans>其特征在于,</seg-trans><seg-comp>该方法包括以下步骤,</seg-comp></div><div class="indep-clm" num="1"><seg-comp>1)在甲醇钠存在下,使间三氟甲基苯乙腈与苯乙酸甲酯进行Claisen缩合反应,得到缩合产物;</seg-comp></div><div class="indep-clm" num="1"><seg-comp>2)将步骤1)得到的缩合产物进行酸水解。</seg-c...
[ { "start": 44, "end": 66, "text": "1-苯基-3-(3-三氟甲基苯基)-2-丙酮", "label": "ChemicalCompound", "smiles": "FC(F)(F)C1=CC=CC(CC(=O)CC2=CC=CC=C2)=C1", "inchikey": "MHBVFQPMQKODRK-UHFFFAOYSA-N", "mention_form": "SYSTEMATIC_NAME" }, { "start": 200, "end": 208, "text": "间三氟甲基苯乙腈", ...
chemner-US20110151089A1-description
US20110151089A1
EN
description
<b class="d_n">[0001]</b>This application is a Continuation of, and claims priority under 35 U.S.C. §120 to, International Application PCT/JP2009/062191, filed Jul. 3, 2009, and claims priority therethrough under 35 U.S.C. §119 to Japanese patent application No. 2008-175709, filed on Jul. 4, 2008, the entireties of whi...
[ { "start": 7304, "end": 7323, "text": "magnesium glutamate", "label": "ChemicalCompound", "smiles": "[Mg++].N[C@@H](CCC([O-])=O)C([O-])=O", "inchikey": "WNPYNOGQURLHSF-DFWYDOINSA-L", "mention_form": "SYSTEMATIC_NAME" }, { "start": 7948, "end": 7962, "text": "glutamic acid...
chemner-US20110151089A1-claim
US20110151089A1
EN
claim
<div class="indep-clm" num="1"><seg-con>1. A composition </seg-con><seg-trans>comprising </seg-trans><seg-refi>magnesium glutamate which can enhance the saltiness of food or drink.</seg-refi></div><div class="indep-clm" num="2"><seg-con>2. A method of enhancing the saltiness of a food or a drink </seg-con><seg-trans>co...
[ { "start": 111, "end": 130, "text": "magnesium glutamate", "label": "ChemicalCompound", "smiles": "[Mg++].N[C@@H](CCC([O-])=O)C([O-])=O", "inchikey": "WNPYNOGQURLHSF-DFWYDOINSA-L", "mention_form": "SYSTEMATIC_NAME" }, { "start": 394, "end": 414, "text": " magnesium glutam...
chemner-US10065976B2-description
US10065976B2
EN
description
<b class="d_n">[0001]</b>This application claims the benefit of U.S. Provisional Application No. 62/102,173, filed Jan. 12, 2015, which is hereby incorporated by reference in its entirety.BACKGROUND<b class="d_n">[0002]</b>The development of earth-abundant and nontoxic catalysts for precision chemical transformations i...
[ { "start": 73515, "end": 73532, "text": " CDCl<sub>3</sub>", "label": "ChemicalCompound", "smiles": "[2H]C(Cl)(Cl)Cl", "inchikey": "HEDRZPFGACZZDS-MICDWDOJSA-N", "mention_form": "UNAMBIGUOUS_FORMULA" }, { "start": 73780, "end": 73823, "text": "1-(2-methylcyclopent-1-en-1-...
chemner-US10065976B2-claim
US10065976B2
EN
claim
<div class="indep-clm" num="1"><seg-con>1. A method of forming a pyrrole or pyrazole compound the method </seg-con><seg-trans>comprising:</seg-trans></div><div class="indep-clm" num="1"><seg-refi>combining at least one compound having a triple bond, at least one azo compound, and at least one Ti(IV) compound under cond...
[ { "start": 65, "end": 72, "text": "pyrrole", "label": "ChemicalCompound", "smiles": "N1C=CC=C1", "inchikey": "KAESVJOAVNADME-UHFFFAOYSA-N", "mention_form": null }, { "start": 76, "end": 84, "text": "pyrazole", "label": "ChemicalCompound", "smiles": "N1C=CC=N1", ...
chemner-KR1020220102156A-description
KR1020220102156A
KR
description
<b class="d_n">[0001]</b><b>관련 출원에 대한 상호 참조</b> <b class="d_n">[0002]</b>본 출원은 2019년 10월 17일에 출원되고 MODULATORS OF BCL6 PROTEOLYSIS AND ASSOCIATED METHODS OF USE로 명명된 미국 특허 가출원 제62/916588호에 대한 우선권을 주장하며, 이는 그 전체가 모든 목적을 위해 참조로서 본원에 통합된다. <b class="d_n">[0003]</b><b>참조로서의 통합</b> <b class="d_n">[0004]</b>미국 특허출원 공개 제2017/0...
[ { "start": 451377, "end": 451422, "text": "삼차-부틸 (2S,6R)-2-(하이드록시메틸)-6-메틸-모르폴린-4-카르복실레이트", "label": "compound", "smiles": "C[C@@H]1CN(C[C@@H](CO)O1)C(=O)OC(C)(C)C", "inchikey": "YJPPRECNUURDRC-BDAKNGLRSA-N", "mention_form": null }, { "start": 451528, "end": 451531, "text"...
chemner-KR1020220102156A-claim
KR1020220102156A
KR
claim
<div class="indep-clm" num="1">청구항 1</div> <div class="indep-clm" num="1">하기 화학 구조식을 갖는 이기능성 화합물:<b>ULM-L-PTM</b>,또는 이의 약학적으로 허용가능한 염, 거울상 이성질체, 입체 이성질체, 용매화물, 다형체로서,여기에서,(a) 상기 ULM은 폰 히펠 린도우(VLM) 및 세레블론(CLM)으로 이루어진 군으로부터 선택되는 E3 유비퀴틴 리가아제에 결합하는 소분자 E3 유비퀴틴 리가아제 결합 모이어티이고;(b) 상기 PTM은 B-세포 림프구 6 단백질(BCL6) 표적화 모이어티를 포함하는...
[ { "start": 672, "end": 674, "text": "Cl", "label": "ChemicalCompound", "smiles": "", "inchikey": "", "mention_form": "UNAMBIGUOUS_FORMULA" }, { "start": 678, "end": 679, "text": "F", "label": "ChemicalCompound", "smiles": "", "inchikey": "", "mention_form"...
chemner-JP7371738B2-description
JP7371738B2
JP
description
【技術分野】<b class="d_n">【0001】</b>本発明は2-クロロ-1,3,3,3-テトラフルオロプロペンの除去方法及び1-クロロ-2,3,3,3-テトラフルオロプロペンの製造方法に関する。【背景技術】<b class="d_n">【0002】</b>従来から、冷凍機用冷媒、空調機器用冷媒、発電システム(廃熱回収発電等)用作動媒体、潜熱輸送装置(ヒートパイプ等)用作動媒体、二次冷却媒体等の熱サイクル用作動媒体としては、クロロトリフルオロメタン(CFC-13)、ジクロロジフルオロメタン(CFC-12)等のクロロフルオロカーボン(CFC)、又はクロロジフルオロメタン(HCFC-22)等のヒドロクロロフルオロカーボン(HCF...
[ { "start": 12959, "end": 12965, "text": "フッ素イオン", "label": "ChemicalCompound", "smiles": "[F-]", "inchikey": "KRHYYFGTRYWZRS-UHFFFAOYSA-M", "mention_form": "SYSTEMATIC_NAME" }, { "start": 12966, "end": 12971, "text": "塩素イオン", "label": "ChemicalCompound", "smiles":...
chemner-JP7371738B2-claim
JP7371738B2
JP
claim
<div class="indep-clm" num="1">【請求項1】</div><div class="indep-clm" num="1"> 2-クロロ-1,3,3,3-テトラフルオロプロペンと1-クロロ-2,3,3,3-テトラフルオロプロペンと1,3,3,3-テトラフルオロプロピンとを含み、前記2-クロロ-1,3,3,3-テトラフルオロプロペンと前記1-クロロ-2,3,3,3-テトラフルオロプロペンの総量に対する前記2-クロロ-1,3,3,3-テトラフルオロプロペンの割合が0.5モル%以下である、混合物。 </div><div class="dep-clm" num="2" parent="1">【請求項2】 前記2-クロ...
[ { "start": 75, "end": 100, "text": "2-クロロ-1,3,3,3-テトラフルオロプロペン", "label": "ChemicalCompound", "smiles": "FC=C(Cl)C(F)(F)F", "inchikey": "RIKAWHYAAZOYDR-UHFFFAOYSA-N", "mention_form": "SYSTEMATIC_NAME" }, { "start": 101, "end": 126, "text": "1-クロロ-2,3,3,3-テトラフルオロプロペン", ...
chemner-TWI822756B-description
TWI822756B
CNT
description
技術領域<b class="d_n">【0001】</b>本發明關於環己烷二羧酸類、二氰基環己烷類、及雙(胺基甲基)環己烷類之製造方法。 先前技術<b class="d_n">【0002】</b>雙(胺基甲基)環己烷類係作為環氧硬化劑、聚醯胺、聚胺甲酸酯等的原料使用的工業上重要的化合物。 <b class="d_n">【0003】</b>就雙(胺基甲基)環己烷類之製造方法而言可列舉幾個。作為具體的製造方法已知有下列方法:對於酞酸類實施氫化反應而製成環己烷二羧酸類,對於環己烷二羧酸類實施醯胺化及脱水反應而製成二氰基環己烷類,對於二氰基環己烷類實施氫化反應以製造雙(胺基甲基)環己烷類。在此,為了製造環己烷二羧酸類,有人使用如專利文獻1...
[ { "start": 9395, "end": 9398, "text": "PTA", "label": "ChemicalCompound", "smiles": "OC(=O)C1=CC=C(C=C1)C(O)=O", "inchikey": "KKEYFWRCBNTPAC-UHFFFAOYSA-N", "mention_form": "UNAMBIGUOUS_ABBREVIATION" }, { "start": 9453, "end": 9455, "text": "酞酸", "label": "ChemicalComp...
chemner-TWI822756B-claim
TWI822756B
CNT
claim
<div class="indep-clm" num="1">1. 一種環己烷二羧酸類之製造方法,具有下列步驟:藉由使氨水溶液中的酞酸類於反應器中在固定床觸媒之存在下與氫接觸,而獲得環己烷二羧酸類、或環己烷二羧酸類氨水溶液;且不含用以過濾觸媒之步驟。</div><div class="indep-clm" num="2">2. 一種二氰基環己烷類之製造方法,具有下列步驟:藉由使利用如申請專利範圍第1項之環己烷二羧酸類之製造方法得到的該環己烷二羧酸類、或環己烷二羧酸類氨水溶液的加熱濃縮物進行氰化反應,而獲得二氰基環己烷類;該加熱濃縮物係藉由將該環己烷二羧酸類氨水溶液加熱並除去至少一部分的水而獲得。</div><div class="d...
[]
chemner-CN121108339A-description
CN121108339A
CN
description
<b class="d_n">[0001]</b>本发明属于免疫治疗领域。更具体地,本发明涉及靶向CD7的抗体,及其在预防、治疗及诊断疾病中的用途。 背景技术 <b class="d_n">[0002]</b>CD7是一种细胞表面糖蛋白,分子量为约40kDa,属于免疫球蛋白超家族的一员。CD7在大多数的T细胞、NK细胞、髓细胞、T细胞急性淋巴细胞白血病/淋巴瘤、急性粒细胞性白血病和慢性粒细胞白血病中表达。据报道,CD7分子通过与其配体K12/SECTM1的结合在T细胞活化期间起到共刺激信号的作用。此外,据报道,破坏小鼠T祖细胞中的CD7分子依然会产生正常的T细胞发育和体内平衡,表明CD7似乎对T细胞的发育和功能不会产生关键性的影响,...
[ { "start": 7422, "end": 7425, "text": "亮氨酸", "label": "ChemicalCompound", "smiles": "CC(C)C[C@@H](N)C(O)=O", "inchikey": "ROHFNLRQFUQHCH-RXMQYKEDSA-N", "mention_form": "SYSTEMATIC_NAME" }, { "start": 7426, "end": 7429, "text": "缬氨酸", "label": "ChemicalCompound", "...
chemner-CN121108339A-claim
CN121108339A
CN
claim
<div class="indep-clm" num="1">1.一种靶向CD7的抗体,其包含轻链可变区和重链可变区,其中所述轻链可变区包含如SEQ ID NO:1所示的CDR-L1、如SEQ ID NO:2所示的CDR-L2、如SEQ ID NO:3所示的CDR-L3,所述重链可变区包含如SEQ ID NO:4所示的CDR-H1、如SEQ ID NO:5所示的CDR-H2、如SEQID NO:6所示的CDR-H3。</div> <div class="dep-clm" num="2" parent="1">2.权利要求1所述的抗体,其中所述轻链可变区与选自SEQ ID NO:7所示的氨基酸序列具有至少90%同一性,所述重链可变区与...
[]
chemner-JP2023552219A-description
JP2023552219A
JP
description
【技術分野】<b class="d_n">【0001】</b>本発明は、有機エレクトロルミネッセンスの技術分野、特に有機エレクトロルミネッセンス素子に適する有機発光材料が提供される技術、特に有イリジウム錯体および有機エレクトロルミネッセンス素子におけるその応用に関するものである。【背景技術】<b class="d_n">【0002】</b>現在、新世代の表示技術としての有機エレクトロルミネッセンス素子(OLED)は、表示および照明技術の両分野でますます注目されており、幅広い応用の見通しがある。ただし、OLED素子の発光効率、駆動電圧、耐用年数などの性能は、市場の応用要件と比べると、強化·改善され続く必要がある。<b class="d...
[ { "start": 32659, "end": 32675, "text": "CDCl<sub>3</sub>", "label": "ChemicalCompound", "smiles": "[2H]C(Cl)(Cl)Cl", "inchikey": "HEDRZPFGACZZDS-MICDWDOJSA-N", "mention_form": "UNAMBIGUOUS_FORMULA" }, { "start": 35645, "end": 35647, "text": "Yb", "label": "ChemicalCo...
chemner-JP2023552219A-claim
JP2023552219A
JP
claim
<div class="indep-clm" num="1">【請求項1】</div><div class="indep-clm" num="1"> Ir(La)(Lb)(Lc)で表される構造を有するイリジウム錯体であって、</div><div class="indep-clm" num="1"> La、Lb及びLcは、母核構造が異なる、母核構造が同一で置換基が異なる、または母核構造が同一で置換基が同一で置換基の位置が異なる、ことにより互いに異なり、La、Lb及びLcは、何れもモノアニオン型二座配位子であり、La、Lb及びLcのうちの任意の二つが互いに接続されることにより多座配位子が形成される、あるいは、La、Lb及びLcが一つの基...
[ { "start": 848, "end": 851, "text": "シアノ", "label": "ChemicalCompound", "smiles": "[C]#N", "inchikey": "JEVCWSUVFOYBFI-UHFFFAOYSA-N", "mention_form": "SYSTEMATIC_NAME" }, { "start": 2201, "end": 2202, "text": "S", "label": "ChemicalCompound", "smiles": "[S]", ...
chemner-US20200215266A1-description
US20200215266A1
EN
description
CLAIM OF PRIORITY<b class="d_n">[0001]</b>This application claims the benefit of priority under 35 U.S.C. § 119(e) of U.S. Provisional Patent Application Ser. No. 62/788,234, filed on Jan. 4, 2019, which is herein incorporated by reference in its entirety.TECHNICAL FIELD<b class="d_n">[0002]</b>This document relates ge...
[ { "start": 44067, "end": 44074, "text": "glucose", "label": "ChemicalCompound", "smiles": "OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O", "inchikey": "GZCGUPFRVQAUEE-SLPGGIOYSA-N", "mention_form": "TRIVIAL_COMMON_NAME" }, { "start": 38912, "end": 38919, "text": "glucose", ...
chemner-US20200215266A1-claim
US20200215266A1
EN
claim
<div class="indep-clm" num="1"><seg-con>1. A method, </seg-con><seg-trans>comprising:</seg-trans></div><div class="indep-clm" num="1"><seg-refi>delivering a glucose therapy to a patient having elevated glucose, wherein delivering the glucose therapy includes reducing glucose using an electrical stimulator to electrical...
[ { "start": 157, "end": 164, "text": "glucose", "label": "ChemicalCompound", "smiles": "OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O", "inchikey": "GZCGUPFRVQAUEE-SLPGGIOYSA-N", "mention_form": "TRIVIAL_COMMON_NAME" }, { "start": 3081, "end": 3088, "text": "glucose", "labe...
chemner-CN113754674B-description
CN113754674B
CN
description
技术领域<b class="d_n">[0001]</b>本发明属于有机化学合成领域,具体涉及一种天然产物Pancratinine&nbsp;B和C的全合成方法。背景技术<b class="d_n">[0002]</b>Pancratinine&nbsp;B和C是2009年首次从石蒜科植物Pancratium&nbsp;canariense中分离出的生物碱,具有抗肿瘤、抗病毒、抗菌等生理活性,其分子骨架结构属于猛它宁(montanine)型生物碱。该类生物碱具有5,11-亚甲基吗吩烷啶结构,含有共同的五元桥杂环(如式I所示),区别主要在于E环上的取代基和立体构型不同。<b class="d_n">[0003]</b><img src...
[ { "start": 12467, "end": 12469, "text": "氩气", "label": "ChemicalCompound", "smiles": "[Ar]", "inchikey": "XKRFYHLGVUSROY-UHFFFAOYSA-N", "mention_form": "SYSTEMATIC_NAME" }, { "start": 12485, "end": 12489, "text": "二氯甲烷", "label": "ChemicalCompound", "smiles": "ClC...
chemner-CN113754674B-claim
CN113754674B
CN
claim
<div class="indep-clm" num="1"><seg-con>1.一种合成化合物8的方法,</seg-con><seg-trans>其特征在于,</seg-trans><seg-comp>包括步骤:</seg-comp></div><div class="indep-clm" num="1"><seg-comp>1)化合物1与氮碘化合物反应,得到化合物2;</seg-comp></div><div class="indep-clm" num="1"><seg-comp>2)化合物2与化合物2’在路易斯酸催化下发生环加成反应,得到化合物3;</seg-comp></div><div class="indep-clm"...
[ { "start": 928, "end": 935, "text": "对甲基苯磺酰基", "label": "ChemicalCompound", "smiles": "CC1=CC=C(C=C1)[S](=O)=O", "inchikey": "OHJXSEODCOULCR-UHFFFAOYSA-N", "mention_form": "SYSTEMATIC_NAME" }, { "start": 951, "end": 953, "text": "羟基", "label": "ChemicalCompound", ...